LGALS9 and breast cancer: Clinically, we further showed that breast cancer patients, after treatment with chemotherapy, had significantly enhanced p-STING and Gal-9 expression in tumor tissues, which explains the regulation of ICD-induced tumor immunosuppression in the tumor microenvironment.